Evaluation of 1, 5 -Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy

Gobor, Luiza Cristina; Volanski, Waldemar; Boritza, Kátia Cristina; Souza, Susan Webber de; Anghebem, Mauren Isfer Anghebem Mauren Isfer; Picheth, Geraldo; Rego, Fabiane Gomes de Moraes.
Braz. J. Pharm. Sci. (Online) ; 57: e19078, 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1345449

Documentos relacionados

  1. Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
  2. Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
  3. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
  4. Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.
  5. Glycemic Status Assessment by the Latest Glucose Monitoring Technologies.
  6. Real-world outcomes with different technology modalities in type 1 diabetes.
  7. The digital frontier: bringing one generation to the next.
  8. Desenvolvimento de rota sintética da Rosiglitazona em processo batelada e microrreator capilar
  9. Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?
  10. Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.